Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus.

MLA

Jones, Peter H., et al. “Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus.” American Journal of Cardiovascular Drugs, vol. 10, no. 2, Mar. 2010, pp. 73–84. EBSCOhost, https://doi.org/10.2165/10061630-000000000-00000.

APA

Jones, P. H., Cusi, K., Davidson, M. H., Kelly, M. T., Setze, C. M., Thakker, K., Sleep, D. J., & Stolzenbach, J. C. (2010). Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus. American Journal of Cardiovascular Drugs, 10(2), 73–84. https://doi.org/10.2165/10061630-000000000-00000

Chicago

Jones, Peter H., Kenneth Cusi, Michael H. Davidson, Maureen T. Kelly, Carolyn M. Setze, Kamlesh Thakker, Darryl J. Sleep, and James C. Stolzenbach. 2010. “Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus.” American Journal of Cardiovascular Drugs 10 (2): 73–84. doi:10.2165/10061630-000000000-00000.